Harel Insurance Investments & Financial Services Ltd. Gamida Cell Ltd. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.16 Billion
Q1 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$0.85 - $1.87 $85 - $188	-101 Reduced 5.25%	1,822 $2,000
Q2 2023 Jul 17, 2023	SELL	$0.73 - $2.37 $310 - $1,009	-426 Reduced 18.14%	1,923 $4,000
Q1 2023 May 02, 2023	BUY	$0.68 - $1.71 $678 - $1,706	998 Added 73.87%	2,349 $2,000
Q4 2022 Jan 26, 2023	BUY	$1.15 - $2.1 $208 - $380	181 Added 15.47%	1,351 $2,000
Q3 2022 Oct 31, 2022	SELL	$1.53 - $3.39 $117 - $261	-77 Reduced 6.17%	1,170 $2,000

Q2 2022 Jul 19, 2022	SELL	$1.73 - $4.29 $98 - $244	-57 Reduced 4.37%	1,247 $2,000
Q1 2022 May 03, 2022	SELL	$2.22 - $4.47 $277 - $558	-125 Reduced 8.75%	1,304 $5,000
Q4 2021 Feb 07, 2022	BUY	$2.2 - $4.46 $3,143 - $6,373	1,429 New	1,429 $4,000

Others Institutions Holding GMDA

# of Institutions

Shares Held

11.4M

Call Options Held

235K

Put Options Held

70.5K

View Full List

About Gamida Cell Ltd.

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

More about GMDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account